Microsoft
MSFT
MARA Holdings
MARA
Meta Platforms
META
4
Oracle
ORCL
5
Amazon
AMZN
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 7.360
- 0.0000.00%
Close May 1 16:00 ET
- 8.116
- +0.756+10.27%
Pre 08:52 ET
1.12BMarket Cap-6.81P/E (TTM)
7.510High7.200Low2.02MVolume7.440Open7.360Pre Close14.84MTurnover2.02%Turnover RatioLossP/E (Static)151.92MShares9.01052wk High5.52P/B734.61MFloat Cap2.99052wk Low--Dividend TTM99.81MShs Float71.250Historical High--Div YieldTTM4.21%Amplitude2.280Historical Low7.357Avg Price1Lot Size
Adaptive Biotechnologies News
Adaptive Biotechnologies Shares Are Trading Higher After the Company Reported Q1 Financial Results and Beat Its EPS and Revenue Estimates.
William Blair Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating
TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $13
Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $11
Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), Adaptive Biotechnologies (ADPT)
Positive Outlook for Adaptive Biotechnologies: Strong Revenue Growth and Strategic Initiatives Support Buy Rating
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), CVS Health (CVS) and Cytokinetics (CYTK)
Express News | Adaptive Biotechnologies Corp : JP Morgan Raises Target Price to $10 From $9
Adaptive Biotechnologies Reports Strong Q1 2025 Growth
Earnings Call Summary | Adaptive Biotechnologies(ADPT.US) Q1 2025 Earnings Conference
Adaptive Biotechnologies Targets 30% MRD Volume Growth in 2025 With Raised Guidance
ADAPTIVE BIOTECH Earnings Results: $ADPT Reports Quarterly Earnings
Adaptive Biotechnologies | 10-Q: Q1 2025 Earnings Report
Earnings Flash (ADPT) Adaptive Biotechnologies Reports Q1 Revenue $52.4M, Vs. FactSet Est of $42.7M
Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
Express News | Adaptive Biotechnologies Corp - Expects Full Year Revenue for Mrd Business to Be Between $180 Mln and $190 Mln
Express News | Adaptive Biotechnologies Q1 Operating Expenses USD 82.047 Million
Express News | Adaptive Biotechnologies Q1 Revenue USD 52.443 Million Vs. IBES Estimate USD 42.7 Million
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
Adaptive Biotechnologies 1Q Loss/Shr 20c >ADPT
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀